Takeda Tries Again To Shake Actos Antitrust Claims
Takeda Pharmaceutical Co. told a New York federal judge Tuesday that it's common practice for drugmakers to draw loose connections between their products and their intellectual property in a national register...To view the full article, register now.
Already a subscriber? Click here to view full article